Glaxo anti-HIV drug approved
Glaxo Wellcome has added to its portfolio of anti-HIV drugs with the approval in 15 European countries of Ziagen. Known as a reverse transcriptase inhibitor, the medicine is intended for use as part
Glaxo Wellcome has added to its portfolio of anti-HIV drugs with the approval in 15 European countries of Ziagen. Known as a reverse transcriptase inhibitor, the medicine is intended for use as part